Costs of diabetes medication among male former elite athletes in later life

Show simple item record Laine, M. K. Kujala, R. Eriksson, J. G. Kautiainen, H. Sarna, S. Kujala, U. M. 2018-06-27T21:21:08Z 2021-12-17T22:02:22Z 2017-04
dc.identifier.citation Laine , M K , Kujala , R , Eriksson , J G , Kautiainen , H , Sarna , S & Kujala , U M 2017 , ' Costs of diabetes medication among male former elite athletes in later life ' , Acta Diabetologica , vol. 54 , no. 4 , pp. 335-341 .
dc.identifier.other PURE: 86070330
dc.identifier.other PURE UUID: 3d55ee78-6967-4ed7-8b1f-c07f7bf6bc27
dc.identifier.other WOS: 000398602300002
dc.identifier.other Scopus: 85001849157
dc.identifier.other ORCID: /0000-0003-3458-1627/work/34564405
dc.identifier.other ORCID: /0000-0002-1848-1514/work/53186121
dc.description.abstract Aims Regular physical activity plays a major role, in both prevention and treatment of type 2 diabetes. Less is known whether vigorous physical activity during young adulthood is associated with costs of diabetes medication in later life. The aim of this study is to evaluate this question. Methods The study population consisted of 1314 former elite-class athletes and 860 matched controls. The former athletes were divided into three groups based on their active career sport: endurance, mixed and power sports. Information on purchases of diabetes medication between 1995 and 2009 was obtained from the drug purchase register of the Finnish Social Insurance Institution. Results The total cost of diabetes medication per person year was significantly lower among the former endurance (mean 81 theta [95% CI 33-151 theta ]) and mixed group athletes (mean 272 theta [95% CI 181- 388 theta]) compared with the controls (mean 376 theta [95% CI 284- 485 theta]), (p <0.001 and p = 0.045, respectively). Of the former endurance athletes, 0.4% used insulin, while 5.2% of the controls used insulin (p = 0.018). Conclusions A career as former endurance, sprint, jumper or team game athlete seems to reduce the costs of diabetes medication in later life. en
dc.format.extent 7
dc.language.iso eng
dc.relation.ispartof Acta Diabetologica
dc.rights.uri info:eu-repo/semantics/openAccess
dc.subject Cost
dc.subject Diabetes
dc.subject Elite-class athlete
dc.subject Medication
dc.subject Physical activity
dc.subject RISK-FACTORS
dc.subject EXERCISE
dc.subject MELLITUS
dc.subject 3121 General medicine, internal medicine and other clinical medicine
dc.title Costs of diabetes medication among male former elite athletes in later life en
dc.type Article
dc.contributor.organization Department of General Practice and Primary Health Care
dc.contributor.organization Clinicum
dc.contributor.organization Johan Eriksson / Principal Investigator
dc.contributor.organization University of Helsinki
dc.contributor.organization Seppo Sarna / Principal Investigator
dc.contributor.organization Department of Public Health
dc.description.reviewstatus Peer reviewed
dc.relation.issn 0940-5429
dc.rights.accesslevel openAccess
dc.type.version publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
10.1007_s00592_016_0947_9.pdf 606.5Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record